Seminars in Liver Disease

Issue S 1 · Volume 23 · 2003 DOI: 10.1055/s-002-2763 Peginterferons in Hepatitis C Virus: Virological, Pharmacokinetic, and Clinical Implications Editor in Chief Paul D. Berk M.D., Guest Editor Emmet B. Keeffe M.D.

INTRODUCTION

001

Keeffe, Emmet B.: Peginterferons in Hepatitis C Virus: Virological, Pharmacokinetic, and Clinical Implications

Full Text
HTML
PDF (40 kb)

003

Pawlotsky, Jean-Michel: Diagnostic Testing in Hepatitis C Virus Infection: Viral Kinetics and Genomics

Full Text
HTML
PDF (177 kb)

013

Powers, Kimberly A.; Dixit, Narendra M.; Ribeiro, Ruy M.; Golia, Preeti; Talal, Andrew H.; Perelson, Alan S.: Modeling Viral and Drug Kinetics: Hepatitis C Virus Treatment with Pegylated Interferon Alfa-2b

Full Text
HTML
PDF (119 kb)

019

Pedder, Simon C. J.: Pegylation of Interferon Alfa: Structural and Pharmacokinetic Properties

Full Text
HTML
PDF (49 kb)

023

Zeuzem, Stefan; Welsch, Christoph; Herrmann, Eva: Pharmacokinetics of Peginterferons

Full Text
HTML
PDF (81 kb)

029

Layden-Almer, Jennifer E.; Layden, Thomas J.: Viral Kinetics in Hepatitis C Virus: Special Patient Populations

Full Text
HTML
PDF (60 kb)

035

Craxi, Antonio; Licata, Anna: Clinical Trial Results of Peginterferons in Combination with Ribavirin

Full Text
HTML
PDF (131 kb)

047

Sherman, Kenneth E.: Implications of Peginterferon Use in Special Populations Infected with HCV

Full Text
HTML
PDF (69 kb)